Form D · Biotechnology
Aloft Biotechnologies, Inc.
Alachua, FL · CIK 0002069497
Offering snapshot reported May 21, 2025 · SEC filing
- Reported sold
- $130K Offering amount: $300K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 21, 2025 | Initial | $130,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-546783
Source: Form D, filed May 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Isaac Finger Baker | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12085 Research Drive, Lab 185
Alachua, FL, 32615
Alachua, FL, 32615